chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Vaccination site pruritus
Clinical narrative: booster injection her arm itched for a week; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (booster injection her arm itched for a week) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. D11F21A, 031LZOA and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (booster injection her arm itched for a week). On 12-Nov-2021, VACCINATION SITE PRURITUS (booster injection her arm itched for a week) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Nov-2021, Blood test: high (High) liver enzymes were out of whack..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications Flu shot were reported. No treatment information was provided.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: Pain; rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) and RASH (rash) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018f21a, 006m20a and 029l20a) for COVID-19 vaccination.     Concomitant products included PREDNISONE, METOPROLOL, TAMSULOSIN and CALCIUM for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (rash). On an unknown date, the patient experienced PAIN (Pain). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN (Pain) and RASH (rash) outcome was unknown.            This case was linked to MOD-2021-392057 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: No new information received
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dysgeusia, Feeling abnormal, Headache, Myalgia
Clinical narrative: Metallic taste; Fingers on the right hand went cold like much more colder than left hand/getting cold; Right arm had tingling; Right arm went numb; Brain fog; Confusion; Metallic taste in the mouth; Headache; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste), PERIPHERAL COLDNESS (Fingers on the right hand went cold like much more colder than left hand/getting cold), VACCINATION SITE PARAESTHESIA (Right arm had tingling), VACCINATION SITE ANAESTHESIA (Right arm went numb) and FEELING ABNORMAL (Brain fog) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Aug-2021, the patient experienced FEELING ABNORMAL (Brain fog), CONFUSIONAL STATE (Confusion), DYSGEUSIA (Metallic taste in the mouth), HEADACHE (Headache) and MYALGIA (Body ache). On an unknown date, the patient experienced DYSGEUSIA (Metallic taste), PERIPHERAL COLDNESS (Fingers on the right hand went cold like much more colder than left hand/getting cold), VACCINATION SITE PARAESTHESIA (Right arm had tingling) and VACCINATION SITE ANAESTHESIA (Right arm went numb). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Headache, at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (BC [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]) for Headache, at a dose of Powder. In August 2021, DYSGEUSIA (Metallic taste in the mouth) had resolved. At the time of the report, DYSGEUSIA (Metallic taste), PERIPHERAL COLDNESS (Fingers on the right hand went cold like much more colder than left hand/getting cold), VACCINATION SITE PARAESTHESIA (Right arm had tingling) and VACCINATION SITE ANAESTHESIA (Right arm went numb) had not resolved and FEELING ABNORMAL (Brain fog), CONFUSIONAL STATE (Confusion), HEADACHE (Headache) and MYALGIA (Body ache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-392038 (Patient Link).
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness, Vaccination site anaesthesia, Vaccination site paraesthesia
Clinical narrative: Metallic taste; Fingers on the right hand went cold like much more colder than left hand/getting cold; Right arm had tingling; Right arm went numb; Brain fog; Confusion; Metallic taste in the mouth; Headache; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste), PERIPHERAL COLDNESS (Fingers on the right hand went cold like much more colder than left hand/getting cold), VACCINATION SITE PARAESTHESIA (Right arm had tingling), VACCINATION SITE ANAESTHESIA (Right arm went numb) and FEELING ABNORMAL (Brain fog) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Aug-2021, the patient experienced FEELING ABNORMAL (Brain fog), CONFUSIONAL STATE (Confusion), DYSGEUSIA (Metallic taste in the mouth), HEADACHE (Headache) and MYALGIA (Body ache). On an unknown date, the patient experienced DYSGEUSIA (Metallic taste), PERIPHERAL COLDNESS (Fingers on the right hand went cold like much more colder than left hand/getting cold), VACCINATION SITE PARAESTHESIA (Right arm had tingling) and VACCINATION SITE ANAESTHESIA (Right arm went numb). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Headache, at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (BC [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]) for Headache, at a dose of Powder. In August 2021, DYSGEUSIA (Metallic taste in the mouth) had resolved. At the time of the report, DYSGEUSIA (Metallic taste), PERIPHERAL COLDNESS (Fingers on the right hand went cold like much more colder than left hand/getting cold), VACCINATION SITE PARAESTHESIA (Right arm had tingling) and VACCINATION SITE ANAESTHESIA (Right arm went numb) had not resolved and FEELING ABNORMAL (Brain fog), CONFUSIONAL STATE (Confusion), HEADACHE (Headache) and MYALGIA (Body ache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-392038 (Patient Link).
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Myalgia, Pyrexia
Clinical narrative: kept sleeping; no appetite; real tired; fever; body aches; chills really bad; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (kept sleeping), DECREASED APPETITE (no appetite), FATIGUE (real tired), PYREXIA (fever) and MYALGIA (body aches) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart attack (had an heart attack). Concurrent medical conditions included Heart disorder.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced SOMNOLENCE (kept sleeping), DECREASED APPETITE (no appetite), FATIGUE (real tired), PYREXIA (fever) and CHILLS (chills really bad). 17-Apr-2021, the patient experienced MYALGIA (body aches). At the time of the report, SOMNOLENCE (kept sleeping), DECREASED APPETITE (no appetite), FATIGUE (real tired), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills really bad) outcome was unknown.            Though patient had heart condition physician advised to take a shot. Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-392003 (Patient Link).
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: kept sleeping; no appetite; real tired; fever; body aches; chills really bad; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (kept sleeping), DECREASED APPETITE (no appetite), FATIGUE (real tired), PYREXIA (fever) and MYALGIA (body aches) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart attack (had an heart attack). Concurrent medical conditions included Heart disorder.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced SOMNOLENCE (kept sleeping), DECREASED APPETITE (no appetite), FATIGUE (real tired), PYREXIA (fever) and CHILLS (chills really bad). 17-Apr-2021, the patient experienced MYALGIA (body aches). At the time of the report, SOMNOLENCE (kept sleeping), DECREASED APPETITE (no appetite), FATIGUE (real tired), PYREXIA (fever), MYALGIA (body aches) and CHILLS (chills really bad) outcome was unknown.            Though patient had heart condition physician advised to take a shot. Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-392003 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes virus infection
Clinical narrative: a herpes outbreak and it is in an area where she has had outbreaks before; This spontaneous case was reported by a nurse and describes the occurrence of HERPES VIRUS INFECTION (a herpes outbreak and it is in an area where she has had outbreaks before) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Overweight and Herpes NOS (The patient has had herpes since the 1980s but it has been a long time since she had an outbreak.) since 1980.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES VIRUS INFECTION (a herpes outbreak and it is in an area where she has had outbreaks before). At the time of the report, HERPES VIRUS INFECTION (a herpes outbreak and it is in an area where she has had outbreaks before) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever/ temperature is 100.1 F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever/ temperature is 100.1 F) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031F21A, 011A21A and 096B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LOSARTAN for Hypertension, VITAMIN B NOS and VITAMIN D NOS for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever/ temperature is 100.1 F). At the time of the report, PYREXIA (Fever/ temperature is 100.1 F) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Nov-2021, Body temperature: 100.1 (High) 100.1 F.         No treatment medications were reported.   This case was linked to MOD-2021-392001, MOD-2021-392187 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Nerve injury, Sensory loss
Clinical narrative: It's like there's some kind of nerve damage.; Patient's left arm, thumb & index finger had the sensation that they were sleep/It's like there's some kind of nerve damage.; This spontaneous case was reported by a consumer and describes the occurrence of NERVE INJURY (It's like there's some kind of nerve damage.) and SENSORY LOSS (Patient's left arm, thumb & index finger had the sensation that they were sleep/It's like there's some kind of nerve damage.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, the patient experienced NERVE INJURY (It's like there's some kind of nerve damage.) and SENSORY LOSS (Patient's left arm, thumb & index finger had the sensation that they were sleep/It's like there's some kind of nerve damage.). At the time of the report, NERVE INJURY (It's like there's some kind of nerve damage.) outcome was unknown and SENSORY LOSS (Patient's left arm, thumb & index finger had the sensation that they were sleep/It's like there's some kind of nerve damage.) was resolving.            No concomitant medications was reported.  Patient had that sensation for the past 4hrs. No treatment medication was reported.   This case was linked to MOD-2021-392085, MOD-2021-392086.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Inappropriate schedule of product administration
Clinical narrative: A patient was administered an expired dose of the Moderna COVID-19 vaccine; Booster dose was administered before 6 months after completing the primary series; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient was administered an expired dose of the Moderna COVID-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose was administered before 6 months after completing the primary series) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: PFIZER BIONTECH COVID-19 VACCINE on 17-May-2021 and PFIZER BIONTECH COVID-19 VACCINE on 03-Jun-2021.    On 17-Nov-2021 at 10:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021 at 10:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient was administered an expired dose of the Moderna COVID-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose was administered before 6 months after completing the primary series). On 17-Nov-2021 at 10:00 AM, EXPIRED PRODUCT ADMINISTERED (A patient was administered an expired dose of the Moderna COVID-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Booster dose was administered before 6 months after completing the primary series) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. Patient was administered by an expired booster dose (more than 12 hours post puncture) of the Moderna COVID-19 vaccine. On 12- Nov-2021, the vial was initially stored in the Refrigerator. On 16-Nov-2021, at 8:00 am  the vail was first punctured. Vial was kept in the  refrigerator post puncture.
Sex: U
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: had the Moderna Booster a week ago 11/10/21, I had a slight reaction with chills about 24 hours later.; This spontaneous case was reported by a nurse and describes the occurrence of CHILLS (had the Moderna Booster a week ago 11/10/21, I had a slight reaction with chills about 24 hours later.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced CHILLS (had the Moderna Booster a week ago 11/10/21, I had a slight reaction with chills about 24 hours later.). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, CHILLS (had the Moderna Booster a week ago 11/10/21, I had a slight reaction with chills about 24 hours later.) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported by the reporter.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dry mouth, Heart rate, Heart rate increased, Throat tightness
Clinical narrative: dry mouth; throat tightening (but confirmed that breathing was not impacted, was able to drink); rapid heart rate; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (dry mouth), THROAT TIGHTNESS (throat tightening (but confirmed that breathing was not impacted, was able to drink)) and HEART RATE INCREASED (rapid heart rate) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A, 040B21A and 069F21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Seizure. Concomitant products included AMLODIPINE and LOSARTAN for Hypertension, LAMOTRIGINE for Seizure.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Nov-2021, the patient experienced DRY MOUTH (dry mouth), THROAT TIGHTNESS (throat tightening (but confirmed that breathing was not impacted, was able to drink)) and HEART RATE INCREASED (rapid heart rate). At the time of the report, DRY MOUTH (dry mouth), THROAT TIGHTNESS (throat tightening (but confirmed that breathing was not impacted, was able to drink)) and HEART RATE INCREASED (rapid heart rate) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Nov-2021, Heart rate: increased (High) Increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment were reported. The patient experienced dry mouth, throat tightening (but confirmed that breathing was not impacted, was able to drink) and rapid heart rate. No prior similar experience as he never had vaccines previously.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm after both doses; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after both doses) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Blood pressure abnormal.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm after both doses). At the time of the report, PAIN IN EXTREMITY (sore arm after both doses) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant informations were reported.  No treatment informations were reported.   This case was linked to MOD-2021-392132 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 10-May-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter No treatment medications were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 16-May-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Induration, Pain, Peripheral swelling
Clinical narrative: red; hard; very sore; swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red), INDURATION (hard), PAIN (very sore) and PERIPHERAL SWELLING (swollen arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced ERYTHEMA (red), INDURATION (hard), PAIN (very sore) and PERIPHERAL SWELLING (swollen arm). At the time of the report, ERYTHEMA (red), INDURATION (hard), PAIN (very sore) and PERIPHERAL SWELLING (swollen arm) outcome was unknown.            No concomitant and treatment information were reported by the reporter
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used/past expiration administration; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/past expiration administration) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 28-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/past expiration administration). On 28-May-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/past expiration administration) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was provided by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Fatigue, Hypotension, Pyrexia
Clinical narrative: Injection site itchiness; She was very powerless and tried yesterday stayed on bed; fever temperature of 102F, Fever; Injection site swelling,  injection site swollen as a size of a lemon; Injection site swollen as a size of a lemon which is very red; Low blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure), VACCINATION SITE SWELLING (Injection site swelling,  injection site swollen as a size of a lemon), VACCINATION SITE ERYTHEMA (Injection site swollen as a size of a lemon which is very red), VACCINATION SITE PRURITUS (Injection site itchiness) and FATIGUE (She was very powerless and tried yesterday stayed on bed) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In November 2021, the patient experienced HYPOTENSION (Low blood pressure) and VACCINATION SITE ERYTHEMA (Injection site swollen as a size of a lemon which is very red). On 16-Nov-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swelling,  injection site swollen as a size of a lemon). On 17-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (Injection site itchiness), FATIGUE (She was very powerless and tried yesterday stayed on bed) and PYREXIA (fever temperature of 102F, Fever). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 17-Nov-2021, PYREXIA (fever temperature of 102F, Fever) had resolved. At the time of the report, HYPOTENSION (Low blood pressure), VACCINATION SITE SWELLING (Injection site swelling,  injection site swollen as a size of a lemon), VACCINATION SITE ERYTHEMA (Injection site swollen as a size of a lemon which is very red), VACCINATION SITE PRURITUS (Injection site itchiness) and FATIGUE (She was very powerless and tried yesterday stayed on bed) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, Blood pressure measurement: 25 (Low) low blood pressure 25beets/1min. On 17-Nov-2021, Body temperature: 102 (High) fever temperature of 102F.         No concomitant medication were provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site itchiness; She was very powerless and tried yesterday stayed on bed; fever temperature of 102F, Fever; Injection site swelling,  injection site swollen as a size of a lemon; Injection site swollen as a size of a lemon which is very red; Low blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure), VACCINATION SITE SWELLING (Injection site swelling,  injection site swollen as a size of a lemon), VACCINATION SITE ERYTHEMA (Injection site swollen as a size of a lemon which is very red), VACCINATION SITE PRURITUS (Injection site itchiness) and FATIGUE (She was very powerless and tried yesterday stayed on bed) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In November 2021, the patient experienced HYPOTENSION (Low blood pressure) and VACCINATION SITE ERYTHEMA (Injection site swollen as a size of a lemon which is very red). On 16-Nov-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swelling,  injection site swollen as a size of a lemon). On 17-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (Injection site itchiness), FATIGUE (She was very powerless and tried yesterday stayed on bed) and PYREXIA (fever temperature of 102F, Fever). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 17-Nov-2021, PYREXIA (fever temperature of 102F, Fever) had resolved. At the time of the report, HYPOTENSION (Low blood pressure), VACCINATION SITE SWELLING (Injection site swelling,  injection site swollen as a size of a lemon), VACCINATION SITE ERYTHEMA (Injection site swollen as a size of a lemon which is very red), VACCINATION SITE PRURITUS (Injection site itchiness) and FATIGUE (She was very powerless and tried yesterday stayed on bed) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, Blood pressure measurement: 25 (Low) low blood pressure 25beets/1min. On 17-Nov-2021, Body temperature: 102 (High) fever temperature of 102F.         No concomitant medication were provided.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Chromaturia, Pain, Urine analysis
Clinical narrative: had some back pain; had soreness, felt achy; regular injection pain, achy after 2nd dose; had little bit chills; patient woke up and urinated in morning the urine was dark; This spontaneous case was reported by a consumer and describes the occurrence of CHROMATURIA (patient woke up and urinated in morning the urine was dark), BACK PAIN (had some back pain), PAIN (had soreness, felt achy), VACCINATION SITE PAIN (regular injection pain, achy after 2nd dose) and CHILLS (had little bit chills) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 010M21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHROMATURIA (patient woke up and urinated in morning the urine was dark). On an unknown date, the patient experienced BACK PAIN (had some back pain), PAIN (had soreness, felt achy), VACCINATION SITE PAIN (regular injection pain, achy after 2nd dose) and CHILLS (had little bit chills). At the time of the report, CHROMATURIA (patient woke up and urinated in morning the urine was dark), BACK PAIN (had some back pain), PAIN (had soreness, felt achy), VACCINATION SITE PAIN (regular injection pain, achy after 2nd dose) and CHILLS (had little bit chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Urine analysis: normal (normal) Blood in urine, but no signs or abnormal lab values which indicated infection.         No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-392285 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: had some back pain; had soreness, felt achy; regular injection pain, achy after 2nd dose; had little bit chills; patient woke up and urinated in morning the urine was dark; This spontaneous case was reported by a consumer and describes the occurrence of CHROMATURIA (patient woke up and urinated in morning the urine was dark), BACK PAIN (had some back pain), PAIN (had soreness, felt achy), VACCINATION SITE PAIN (regular injection pain, achy after 2nd dose) and CHILLS (had little bit chills) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 010M21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHROMATURIA (patient woke up and urinated in morning the urine was dark). On an unknown date, the patient experienced BACK PAIN (had some back pain), PAIN (had soreness, felt achy), VACCINATION SITE PAIN (regular injection pain, achy after 2nd dose) and CHILLS (had little bit chills). At the time of the report, CHROMATURIA (patient woke up and urinated in morning the urine was dark), BACK PAIN (had some back pain), PAIN (had soreness, felt achy), VACCINATION SITE PAIN (regular injection pain, achy after 2nd dose) and CHILLS (had little bit chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Urine analysis: normal (normal) Blood in urine, but no signs or abnormal lab values which indicated infection.         No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-392285 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Chills, Tremor, Urticaria
Clinical narrative: Hives on her back, chest, neck and head; Shaking; Chills; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives on her back, chest, neck and head), TREMOR (Shaking) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Nov-2021, the patient experienced URTICARIA (Hives on her back, chest, neck and head), TREMOR (Shaking) and CHILLS (Chills). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 19-Nov-2021 for Hives, at a dose of 2 Benadryl and PARACETAMOL (TYLENOL [PARACETAMOL]) on 19-Nov-2021 at a dose of UNK dosage form. At the time of the report, URTICARIA (Hives on her back, chest, neck and head), TREMOR (Shaking) and CHILLS (Chills) outcome was unknown.            Patient received the first dose of Pfizer( EL6204) and second dose of Pfizer (EP6955) on unspecified dates and didn't experienced any side effects for both the doses.  No Treatment medication was reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site induration, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: Stiff and sore right arm when lifting arm above shoulder.; sore right injection site arm after second shot/Stiff and sore right arm when lifting arm above shoulder.; Stiff and sore right arm when lifting arm above shoulder.; Inappropriate schedule of vaccine administration; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Stiff and sore right arm when lifting arm above shoulder.), VACCINATION SITE PAIN (sore right injection site arm after second shot/Stiff and sore right arm when lifting arm above shoulder.), VACCINATION SITE INDURATION (Stiff and sore right arm when lifting arm above shoulder.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 077C21B) for COVID-19 vaccination.     Previously administered products included for an unreported indication: JANSSEN COVID-19 VACCINE (Patient received her Johnson and Johnson covid-19 vaccine for her first vaccine Arm was sore and patient had a headache. Jansen lot number 1808978 Patient had a headache the first two days after the vaccine. Patient had a sore right arm.).    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration). On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Stiff and sore right arm when lifting arm above shoulder.), VACCINATION SITE PAIN (sore right injection site arm after second shot/Stiff and sore right arm when lifting arm above shoulder.) and VACCINATION SITE INDURATION (Stiff and sore right arm when lifting arm above shoulder.). On 18-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration) had resolved. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Stiff and sore right arm when lifting arm above shoulder.), VACCINATION SITE PAIN (sore right injection site arm after second shot/Stiff and sore right arm when lifting arm above shoulder.) and VACCINATION SITE INDURATION (Stiff and sore right arm when lifting arm above shoulder.) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received expired vaccine beyond 12 hours post puncture; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond 12 hours post puncture) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021 at 10:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021 at 10:00 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond 12 hours post puncture). On 18-Nov-2021 at 10:00 AM, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond 12 hours post puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Healthcare worker stated that 8 patients received the booster dose with an expired vial more than 12 hours post punctured. The vial was initially stored in the refrigerator on 10-Nov-2021. On 17-Nov-2021, the vial was first punctured at 12 noon. The vial did not undergo any temperature excursions.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Light fatigue after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Light fatigue after the first dose) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced FATIGUE (Light fatigue after the first dose). At the time of the report, FATIGUE (Light fatigue after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-392438 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Muscle spasms, Neck pain, Pain in extremity, Pain in jaw
Clinical narrative: Arm went into spasm, like it hit a nerve; Shooting pain up left side of face into temple; Pain going down jaw into her neck left side; Pain going down jaw into her neck left side; Pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Arm went into spasm, like it hit a nerve), FACIAL PAIN (Shooting pain up left side of face into temple), PAIN IN JAW (Pain going down jaw into her neck left side), NECK PAIN (Pain going down jaw into her neck left side) and PAIN IN EXTREMITY (Pain in the arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced MUSCLE SPASMS (Arm went into spasm, like it hit a nerve), FACIAL PAIN (Shooting pain up left side of face into temple), PAIN IN JAW (Pain going down jaw into her neck left side), NECK PAIN (Pain going down jaw into her neck left side) and PAIN IN EXTREMITY (Pain in the arm). At the time of the report, MUSCLE SPASMS (Arm went into spasm, like it hit a nerve), FACIAL PAIN (Shooting pain up left side of face into temple), PAIN IN JAW (Pain going down jaw into her neck left side), NECK PAIN (Pain going down jaw into her neck left side) and PAIN IN EXTREMITY (Pain in the arm) outcome was unknown.            Nurse told her to alternate between taking ibuprofen and Tylenol daily.  No concomitant medications reported.   This case was linked to MOD-2021-393216 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: site of the injection getting bigger; site of the injection got red; site of the injection itches and bothers them because of the itching; site of the injection is swollen; site of the injection stings; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (site of the injection getting bigger), VACCINATION SITE ERYTHEMA (site of the injection got red), VACCINATION SITE PRURITUS (site of the injection itches and bothers them because of the itching), VACCINATION SITE SWELLING (site of the injection is swollen) and VACCINATION SITE PAIN (site of the injection stings) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Nov-2021, the patient experienced VACCINATION COMPLICATION (site of the injection getting bigger), VACCINATION SITE ERYTHEMA (site of the injection got red), VACCINATION SITE PRURITUS (site of the injection itches and bothers them because of the itching), VACCINATION SITE SWELLING (site of the injection is swollen) and VACCINATION SITE PAIN (site of the injection stings). At the time of the report, VACCINATION COMPLICATION (site of the injection getting bigger), VACCINATION SITE ERYTHEMA (site of the injection got red), VACCINATION SITE PRURITUS (site of the injection itches and bothers them because of the itching), VACCINATION SITE SWELLING (site of the injection is swollen) and VACCINATION SITE PAIN (site of the injection stings) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.; Sender's Comments: Non-serious Case